Literature DB >> 2873037

Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.

P G Hugenholtz, P W Serruys, A Fleckenstein, W Nayler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873037     DOI： 10.1093/oxfordjournals.eurheartj.a062064

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  8 in total

Review 1.  Secondary prevention after myocardial infarction: effects of beta blocking agents and calcium antagonists.

Authors:  P Depelchin; J Sobolski; M Jottrand; C Flament
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 2.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 3.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 4.  Myocardial infarction. Secondary prevention with nifedipine.

Authors:  W Rafflenbeul; F Ebner
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

Review 6.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 7.  How do calcium antagonists differ in clinical practice?

Authors:  R Ferrari; F Cucchini; R Bolognesi; T Bachetti; A Boraso; P Bernocchi; G Gaia; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 8.  Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.

Authors:  R Massingham; P A Van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.